LILARIX

Welcome to the Brand page for “LILARIX”, which is offered here for In the statement, column 2, line through 4 priority claimed under sec. 44 (d) on united kingdom application no. 2340942, filed 8-15-2003, reg no. 3428216, dated 3-15-2005, expires 10-29-2013 should be deleted, and priority claimed under sec. 44 ( d ) on united kingdom application no. 2340942, filed 8-15-2003, reg no 2340942, date 8-15-2003, expires 8-15-2013;vaccines for human use;.

Its status is currently believed to be active. Its class is unavailable. “LILARIX” is believed to be currently owned by “GlaxoSmithKline Biologicals, S. A.”


Owner:
GLAXOSMITHKLINE BIOLOGICALS, S. A.
Owner Details
Description:
In the statement, Column 2, line through 4 priority claimed under sec. 44 (D) on united kingdom application no. 2340942, filed 8-15-2003, reg no. 3428216, dated 3-15-2005, expires 10-29-2013 should be deleted, and priority claimed under sec. 44 ( d ) on united kingdom application no. 2340942, filed 8-15-2003, reg no 2340942, date 8-15-2003, expires 8-15-2013;Vaccines for human use;
Categories: STATEMENT